CBD

Cannabis is a Safe and Effect for the Treatment of Fibromyalgia

July 9, 2019 Anti-inflammatory properties, Arthritis, Cannabinoids, Cannabis, Cannabis Science, CBD, Fibromyalgia, Future Medicine, Multiple Sclerosis, Muscle Pain, Occasional Use, Pain, Placebo-Controlled, Science, Synthetic Cannabinoids, THC

Safety and Efficacy of Medical Cannabis in Fibromyalgia

A recent study has concluded that cannabis is a safe and effective treatment for patients suffering from fibromyalgia symptoms.

Fibromyalgia is a disorder characterized by widespread pain, fatigue, and issues sleeping. Cannabis is well known for its ability to treat pain, especially in lieu of opioids as the side effects are minimal and the risk of addiction minimal. This study found that over 200 patients were greatly benefited by cannabis as it moderated their pain and improved their mood. Future studies should aim to directly compare cannabis-based treatment with the currently accepted methods of fibromyalgia treatment to validate efficacy.

This study highlights how beneficial cannabis can be for those patients who are treatment-resistant for the general treatment of most disorders, especially when pain is involved. Cannabis has been proven to be much safer than opioids, and yet our lack of complete information, concerning the exact mechanisms of the endocannabinoid system and how different cannabinoids act on those mechanisms severely limits our ability to offer practical, novel therapies. Cannabis has previously been shown to be beneficial for treatment-resistant forms of epilepsy and depression, which holds promise when continuing to look for novel treatments for other disorders that have proven difficult to treat.

View this review (yellow link) or download:

Safety and Efficacy of Medical Cannabis in Fibromyalgia Download

This paper is also stored here: http://bit.ly/2XpsGJr inside the CED Foundation Archive

To explore related information, click the keywords below:

A Report on the Psychiatric Effects of Cannabis Demonstrates the Progress and the Gaps in Cannabis Knowledge

July 8, 2019 Adverse Effects, Anti-inflammatory properties, Anxiety, Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Cognition, Mental Health, Muscle Pain, Neuropathy, Occasional Use, Science, Stigma, THC

Psychiatric effects of cannabis

A report published by the British Journal of Psychiatry in 2001 demonstrates the progress the medical community has made but also what gaps still need to be filled in when utilizing cannabis. This report found that excess consumption of cannabis leads to feelings of panic and anxiety and that 15% of those willing to respond to a survey experienced acute psychotic symptoms. It was also found that cannabis dependence can occur, as well as withdrawal, which can last for close to a week. This article was a review that synthesized relevant studies but also claimed that the casual conclusions of these papers were difficult to find or replicate.

This paper is interesting given its age considering it put out what was current data but then ended by stating the casual conclusions of each paper may not stand. 18 years later, some of the data has stood, and some have not. Users can gain a tolerance to cannabis but many are looking to mitigate it. The author uses the word dependence when discussing cannabis which is a word that holds weight and is up for debate. Intoxicating cannabinoids, like THC, affect the reward center, but non-altering cannabinoids, such as CBD, tend to work more noticeably outside of the brain, although all have mixed effects in both regions. Cannabinoids are not all the same, apply quite differently to various ailments, and have divergent effects. Blanketing an entire crop with a misinformed warning label seems irresponsible and unduly harsh. Users or those looking into cannabis-based medicine are encouraged to do their research.

View this review (yellow link) or download:

Psychiatric effects of cannabis Download

This paper is also stored here: http://bit.ly/2XrRPmT inside the CED Foundation Archive

To explore related information, click the keywords below:

Video: Cannabinoid Delivery Systems for Pain and Inflammation Treatment

July 3, 2019 Anti-inflammatory properties, Arthritis, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Dermatology / Skin, Dronabinol, Future Medicine, Insomnia, Mental Health, Multiple Sclerosis, Muscle Pain, Nabilone, Neuropathy, Pain, Placebo-Controlled, Products, Science, Sleep, Stigma, Synthetic Cannabinoids, THC, Video

A 2018 literature review summarizes the various ways patients can consume cannabis (orally, topically, etc.) and the pain reductions associated with each method. The review focuses on the treatment of multiple sclerosis, cancer, anorexia, arthritis, and other painful disorders.

View this review (yellow link) or download:

Cannabinoid Delivery Systems for Pain and Inflammation Treatment Download

This paper is also stored here: http://bit.ly/2TSZ2Wr inside the CED Foundation Archive

80%: Cannabis extremely helpful for pain; 82%: helped reduce or stop over-the-counter medications; 88% able to stop taking opioid painkillers

July 2, 2019 Anti-inflammatory properties, Arthritis, Cannabinoids, Cannabis, Cannabis Science, Case Study, CBD, Fibromyalgia, Future Medicine, Insomnia, Muscle Pain, Neuropathy, Opiates, Pain, Science, Sleep, THC

“The study, published in the Journal of Psychoactive Drugs, which looked at 1,000 people taking legalized marijuana in an American state found that among the 65% of people taking cannabis for pain, 80% found it was very or extremely helpful.”

“82% of these people being able to reduce, or stop taking over the counter pain medications, and 88% being able to stop taking opioid painkillers.”

“74% of the 1,000 interviewees bought it to help them sleep – 84% of whom said the marijuana had helped them, and over 83% said that they had since reduced or stopped taking over-the-counter or prescription sleep aids.”

“The study adds weight to the theory that widening access to medical cannabis could lower the use of prescription painkillers, allowing more people to manage and treat their pain without relying on opioid prescription drugs that have dangerous side effects.”

“This is backed up with other research that shows that states with medical cannabis laws have a 6.38% lower rate of opioid prescribing and that Colorado’s adult-use cannabis law is associated with a relative reduction in opioid overdose death rate from 1999 to 2010.”

“”Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen cause GI bleeding or kidney damage with chronic use. Paracetemol (Acetaminophen) toxicity is the second most common cause of liver transplantation worldwide, and is responsible for 56,000 ER visits, 2600 hospitalizations, and 500 deaths per year in the U.S.”

Link to news brief: https://eurekalert.org/pub_releases/2019-07/tfg-cmb062819.php

View this review (yellow link) or download:

This paper is also stored here: http://bit.ly/2JmB7Lv inside the CED Foundation Archive

To explore related information, click the keywords below:

Video: Cannabinoid Intervention for PTSD: Where to Next?

July 2, 2019 Anxiety, Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CBD, Depression, Future Medicine, Insomnia, Memory, PTSD, Sleep, Stigma, THC, Veterans

The endocannabinoid system has long been recognized as a promising target for PTSD treatment.

Here, a 2018 literature review summarizes the risks and benefits of cannabis as a treatment option. Watch our video adaptation, and review the source literature, below:

View this review (yellow link) or download:

Cannabinoid interventions for PTSD: Where to next?Download

This paper is also stored here: http://bit.ly/2XgnrXn inside the CED Foundation Archive

To explore related information, click the keywords below:

Non-Psychoactive Cannabis Treatments for Chronic Muscle Pain

July 2, 2019 Addiction, Anti-inflammatory properties, Anxiety, Cannabinoids, Cannabis, Cannabis Science, CBD, CBN, Multiple Sclerosis, Muscle Pain, Neuropathy, Pain, Science

Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain

Some of the non-psychoactive cannabinoids in cannabis, cannabidiol (CBD) and cannabinol (CBN), have recently been found to produce analgesic effects (pain relief) in mouse models. A combination of CBD and CBN causes a decrease in sensitization of muscles, leading researchers to believe the combination could provide relief for those suffering from chronic muscle pain disorders. Cannabis products are already being prescribed for chronic pain disorders and this new study provides evidence that cannabis-based medicine can also be applicable when treating chronic pain associated with disorders such as fibromyalgia and temporomandibular disorders.

View this review (yellow link) or download:

Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain Download

This paper is also stored here: http://bit.ly/2L1AF8d inside the CED Foundation Archive

Patients are Unclear on Cannabis Dosing

July 2, 2019 Cannabinoids, Cannabis, Cannabis Education, Cannabis News, CB1, CB2, CBD, Dosing, Epilepsy, Future Medicine, Products, THC

Dr. Ernest found that 82% of her epileptic patients found cannabis treatment helpful, but she also found that many of them were unaware of the doses they were taking or the levels of THC and CBD. Doctors and patients alike need to learn about dosing to maximize their health benefits http://bit.ly/2J29kkB

To explore related information, click the keywords below:

Cannabidiol Treatment for Parkinson’s Disease

July 1, 2019 Aging, Anti-inflammatory properties, Anxiety, Arthritis, Autoimmunity, Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Depression, DSM-5, Elderly, Future Medicine, Insomnia, Memory, Muscle Pain, Neuropathy, Parkinson's Disease, Science

Cannabidiol: a hope to treat non‑motor symptoms of Parkinson’s Disease Patients

Cannabidiol (CBD) has recently been postulated as an ideal drug to address the treatment of non-motor symptoms of Parkinson’s Disease (PD) due to its multifaceted mechanism of action. The plethora of effects of CBD includes anti-inflammatory, neuroprotective, anxiolytic, and antipsychotic actions, which improve non-motor symptoms of PD and lift the quality of life for patients coping with the illness. Further research is recommended to garner support for FDA approval.

View this review (yellow link) or download:

Cannabidiol: A hope to treat non‑motor symptoms of Parkinson’s disease patients Download

This paper is also stored here: http://bit.ly/2KXTb0Y inside the CED Foundation Archive

To explore related information, click the keywords below:

Development of Cannabis-Based Treatment for Bipolar Disorder

June 30, 2019 Addiction, Adolescents, Adverse Effects, Anxiety, Bipolar Disorder, Cannabinoids, Cannabis, Cannabis Science, CB1, CB2, CBD, Cognition, Depression, DSM-5, Elderly, Future Medicine, Hypomania, Mental Health, Mood, Neuropathy, Science, THC

Bipolar disorder and the endocannabinoid system

A recently published article serves as a call for research to be conducted to discover how cannabis could impact the management of bipolar disorder (BD). Presented in the article is a full review of the advantages and disadvantages of cannabis-based medicine in the treatment of BD and provides insight into possible mechanisms might affect the pathophysiology of the disorder. The insights listed within the article provide the rationale for examining the endocannabinoid system, specifically the cannabinoid receptor 2, with the hopes of finding therapeutic targets for mood control associated with BD.

View this review (yellow link) or download:

Bipolar disorder and the endocannabinoid system Download

This paper is also stored here: http://bit.ly/2FfJXK6 inside the CED Foundation Archive

To explore related information, click the keywords below:

Regulation of hemp in Tennessee

June 28, 2019 Cannabis, Cannabis News, CBD, Dispensaries, Hemp, History, Legislation, Regulation, Tennessee, THC

Tennessee is yet another state looking to regulate hemp effectively, and a proposed solution to this is on-the-go testing kits to determine THC levels in hemp products. If executed well, this could prevent many from being charged with possession of cannabis and save money in the courts and prison systems http://bit.ly/2ISjm7V

To explore related information, click the keywords below: